UnknownEarly Phase 1

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

120 participantsStarted 2016-08

Plain-language summary

Prospective study of the effect of Talc Pleurodesis vs. Indwelling Pleural catheter in treatment of patients with malignant pleural effusion

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients with recurrent symptomatic pleural effusion, the diagnosis was obtained by : - positive cytology for malignant cells in the fluid.
✓. Patients who underwent prior to involvement in the study, draining of the pleural fluid with symptomatic improvement.
✓. Patients with rate of fluid accumulation less than 30 days.
✓. Patient who signed informed consent about being involved in the study.

✕. Patients under the age of 18 years.
✕. Female patients who are Pregnant or nursing.
✕. Patients with rate of pleural effusion accumulation is more than 30 days.
✕. Patients who didn't show clinical improvement post proper draining of the fluid
✕. Patients who are hemodynamically or respiratory unstable.
✕. Patients with Empyema.
✕. Patients who are non functioning/ not active according to the Performance status.
✕. The type of malignancy which cause the malignant pleural effusion is Lymphoma.

change in Quality of Life

Timeframe: one year of regular follow up.

NCT IDNCT02825095

SponsorRambam Health Care Campus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05

Ran Kremer, MD